title: Competent psychopharmacology.
abstract: There is little doubt that undergraduate and post-graduate training of physicians, pharmacists, and nurses is insufficient to prepare them to use psychotropics safely and effectively, especially in the context of their expanded off-label uses. Therefore, the development of competencies in psychotropic prescribing needs to be approached as a long-term, practice-based learning commitment. Proposed are the abilities and knowledge components necessary for safe and effective use of psychotropics. Typical challenges in prescribing for chronic and recurrent illnesses include highly variable responses and tolerability, drug interactions, and adverse effects that can be serious, irreversible, and even fatal. Prescribing psychotropics is further complicated by negative public and professional reports and growing patient concerns about the quality of care, and questions about the efficacy, safety, and addictive risks of psychotropics. Increased efforts are needed to enhance clinical training and knowledge in psychopharmacology among trainees and practising clinicians, with more comprehensive and sustained attention to the assessment of individual patients, and greater reliance on patient education and collaboration. Improved competence in psychotropic prescribing should lead to more informed, thoughtful, and better-targeted applications as one component of more comprehensive clinical care.
authors.affiliation: Professor, Department of Psychiatry and College of Pharmacy, Dalhousie University, Halifax, Nova Scotia.
authors.forename: David M
authors.initials: DM
authors.lastname: Gardner
mesh_terms: D002170:Canada; D002983:Clinical Competence; D003299:Cooperative Behavior; D003479:Curriculum / Q000639:trends; D004502:Education, Medical, Continuing; D004509:Education, Nursing, Continuing; D004513:Education, Pharmacy, Continuing; D006801:Humans; D033183:Interdisciplinary Communication; D056687:Off-Label Use; D010353:Patient Education as Topic / Q000639:trends; D011600:Psychopharmacology / Q000193:education*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D011619:Psychotropic Drugs